New cancer clinical trial: KeyLargo: Pembrolizumab + Oxaliplatin + Capecitabine in Gastric Cancer
Published on: November 15, 2017 at 10:00AM
Conditions: Gastric Cancer; Esophagus Cancer
Intervention: Drug: Oxaliplatin+Capecitabine+Pembrolizumab
Sponsors: Duke University; Merck Sharp & Dohme Corp.
Not yet recruiting
http://ift.tt/2zK8bue
More Stories
‘My 401k Misses You’: Black Woman Pumped To Meet Donald Trump In Philadelphia – July 18, 2023 at 04:56PM
Energy Provider Warns of Impending ‘Crisis,’ ‘Blackout Conditions’ Driven By Biden Plans – July 18, 2023 at 04:20PM
Dog starts barking at cows crossing a bridge, so the cows stop to have a look. – July 17, 2023 at 02:27PM